{
 "cells": [
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# IKZF1\n",
    "[common variable immunodeficiency-13 (CVID13)](https://omim.org/entry/616873) is caused by heterozygous mutation in the IKZF1 gene. CVID13 is an autosomal dominant primary immunodeficiency disorder characterized by recurrent bacterial infections, mainly affecting the respiratory tract, and associated with hypogammaglobulinemia and decreased numbers of B cells. The age at onset of clinical features can range from infancy to adulthood.\n",
    "Many published IKZF1 vairants are thought to be loss of function ([PMID: 31057532](https://pubmed.ncbi.nlm.nih.gov/31057532/)). Heterozygous mutations affecting amino acid N159 located in the DNA-binding domain of IKZF1 are thought to act in a dominant-negative fashion and were reported to be associated with early-onset and severe manifestations often including\n",
    "Pneumocystis jirovecii pneumonia ([PMID:](29889099)https://pubmed.ncbi.nlm.nih.gov/29889099/).\n",
    "Here, we test a cohort of individuals with pathogenic IKZF1 variants.\n",
    "\n",
    "Germline variants in IKZF1 encoding for the lymphoid transcription factor IKAROS, are associated with inborn errors of immunity characterized by immune dysregulation, autoimmunity and an increased risk for malignancy. IKAROS is important in hematopoietic development, but also required for the development of autoimmune regulator-positive (AIRE+) mTEC (Sin et al. 2023).  Knowledge of the genotype-phenotype correlations such as the ones described above has the great potential to improve patient management."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Loaded HPO v2025-01-16\n",
      "Using gpsea version 0.9.6.dev0\n"
     ]
    }
   ],
   "source": [
    "import hpotk\n",
    "import gpsea\n",
    "\n",
    "store = hpotk.configure_ontology_store()\n",
    "hpo = store.load_minimal_hpo()\n",
    "print(f'Loaded HPO v{hpo.version}')\n",
    "print(f\"Using gpsea version {gpsea.__version__}\")"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### IKZF\n",
    "We used the [Matched Annotation from NCBI and EMBL-EBI (MANE)](https://www.ncbi.nlm.nih.gov/refseq/MANE/) transcript and the corresponding protein identifier for IKZF."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [],
   "source": [
    "from gpsea.preprocessing import configure_default_protein_metadata_service\n",
    "gene_symbol = 'IKZF1'\n",
    "mane_tx_id = 'NM_006060.6'\n",
    "mane_protein_id = 'NP_006051.1' # DNA-binding protein Ikaros isoform 1\n",
    "pms = configure_default_protein_metadata_service()\n",
    "protein_meta = pms.annotate(mane_protein_id)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Loaded 82 phenopackets\n",
      "Individuals Processed: 100%|██████████| 82/82 [00:17<00:00,  4.62 individuals/s]\n",
      "Validated under permissive policy\n",
      "No errors or warnings were found\n"
     ]
    }
   ],
   "source": [
    "from ppktstore.registry import configure_phenopacket_registry\n",
    "from gpsea.preprocessing import configure_caching_cohort_creator, load_phenopackets\n",
    "\n",
    "phenopacket_registry = configure_phenopacket_registry()\n",
    "with phenopacket_registry.open_phenopacket_store(\"0.1.24\") as ps:\n",
    "    phenopackets = tuple(ps.iter_cohort_phenopackets(gene_symbol))\n",
    "print(f'Loaded {len(phenopackets)} phenopackets')\n",
    "\n",
    "cohort_creator = configure_caching_cohort_creator(hpo)\n",
    "cohort, validation = load_phenopackets(  \n",
    "    phenopackets=phenopackets,\n",
    "    cohort_creator=cohort_creator,\n",
    ")\n",
    "validation.summarize()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "    <style>\n",
       "        /** Light theme is the default */\n",
       "        :root {\n",
       "            --gpsea-color-text: black;\n",
       "            --gpsea-color-link-text: rgb(0, 118, 187);\n",
       "            --gpsea-color-link-hover: rgb(0, 99, 156);\n",
       "            --gpsea-color-primary-a0: #2f5170;\n",
       "            --gpsea-color-primary-a10: #4778a5;\n",
       "            --gpsea-color-primary-a20: #5995ce;\n",
       "            --gpsea-color-primary-a60: LightSkyBlue;\n",
       "            --gpsea-color-surface-a0: #fcfcfc;\n",
       "            --gpsea-color-surface-a10: #ffffff;\n",
       "            --gpsea-color-surface-a20: #b3b3b3;\n",
       "            --gpsea-color-surface-a30: #8d8d8d;\n",
       "            --gpsea-color-surface-a40: #646464;\n",
       "            --gpsea-color-surface-a50: #000000;\n",
       "        }\n",
       "\n",
       "        /** Dark theme */\n",
       "        /*\n",
       "        @media (prefers-color-scheme: dark) {\n",
       "            :root {\n",
       "                --gpsea-color-text: rgb(240, 240, 240);\n",
       "                --gpsea-color-link-text: rgb(240, 240, 240);\n",
       "                --gpsea-color-link-hover: lightblue;\n",
       "                --gpsea-color-primary-a0: #64a3df;\n",
       "                --gpsea-color-primary-a10: #5286b8;\n",
       "                --gpsea-color-primary-a20: #375c7e;\n",
       "                --gpsea-color-primary-a60: #233b52;\n",
       "                --gpsea-color-surface-a0: #121212;\n",
       "                --gpsea-color-surface-a10: #282828;\n",
       "                --gpsea-color-surface-a20: #3f3f3f;\n",
       "                --gpsea-color-surface-a30: #575757;\n",
       "                --gpsea-color-surface-a40: #717171;\n",
       "                --gpsea-color-surface-a50: #8b8b8b;\n",
       "            }\n",
       "        }\n",
       "        */\n",
       "\n",
       "        #gpsea-body {\n",
       "            max-width: 1600px;\n",
       "            color: var(--gpsea-color-text);\n",
       "            background-color: var(--gpsea-color-surface-a0);\n",
       "            padding: 10px 0;\n",
       "        }\n",
       "\n",
       "        #gpsea-body {\n",
       "\n",
       "            h1,\n",
       "            h2,\n",
       "            h3,\n",
       "            h4,\n",
       "            h5 {\n",
       "                color: var(--gpsea-color-primary-a0);\n",
       "            }\n",
       "\n",
       "            a {\n",
       "                color: var(--gpsea-color-link-text);\n",
       "                text-decoration: none;\n",
       "            }\n",
       "\n",
       "            a:hover {\n",
       "                color: var(--gpsea-color-link-hover);\n",
       "            }\n",
       "\n",
       "            #cohort-summary {\n",
       "                max-width: 800px;\n",
       "            }\n",
       "\n",
       "            td {\n",
       "                padding: 5px 0;\n",
       "            }\n",
       "\n",
       "            .cards {\n",
       "                display: flex;\n",
       "                flex-flow: row wrap;\n",
       "                align-items: top;\n",
       "                gap: 1rem;\n",
       "            }\n",
       "\n",
       "            .card {\n",
       "                border-radius: 5px;\n",
       "                padding: 0px 10px;\n",
       "                background: var(--gpsea-color-surface-a10);\n",
       "                border: 1px solid var(--gpsea-color-surface-a30);\n",
       "                box-shadow: 0 4px 8px var(--gpsea-color-surface-a30);\n",
       "            }\n",
       "\n",
       "            table {\n",
       "                width: 100%;\n",
       "                border-collapse: collapse;\n",
       "                margin: 10px 0;\n",
       "                font-size: 0.9em;\n",
       "                font-family: sans-serif;\n",
       "                box-shadow: 0 0 20px rgba(0, 0, 0, 0.15);\n",
       "                border: 1px solid var(--gpsea-color-primary-a60);\n",
       "            }\n",
       "\n",
       "            th {\n",
       "                text-align: left;\n",
       "                padding: 2px;\n",
       "                font-weight: bold;\n",
       "                font-size: 120%;\n",
       "                color: var(--gpsea-color-text);\n",
       "                background-color: var(--gpsea-color-primary-a60);\n",
       "            }\n",
       "\n",
       "            table td,\n",
       "            tr {\n",
       "                text-align: left;\n",
       "                padding: 0px 5px;\n",
       "            }\n",
       "\n",
       "            tr:nth-child(even) {\n",
       "                background-color: var(--gpsea-color-surface-a10);\n",
       "            }\n",
       "\n",
       "            tr:nth-child(odd) {\n",
       "                background-color: var(--gpsea-color-surface-a20);\n",
       "            }\n",
       "\n",
       "            caption {\n",
       "                caption-side: top;\n",
       "                text-align: left;\n",
       "                padding-bottom: 10px;\n",
       "                font-weight: bold;\n",
       "            }\n",
       "        }\n",
       "    </style>\n",
       "    <div id=\"gpsea-body\">\n",
       "        \n",
       "\n",
       "<h1>GPSEA cohort analysis</h1>\n",
       "<div id=\"cohort-summary\">\n",
       "  <p>\n",
       "    Successfully loaded 82 individuals.\n",
       "\n",
       "    \n",
       "    37 were recorded as male,\n",
       "    34 as female,\n",
       "    and 11 as unknown sex.\n",
       "\n",
       "    \n",
       "    \n",
       "    77 were reported to be alive at the time of last encounter,\n",
       "    5 were deceased,\n",
       "    and vital status was unreported for 0 individuals.\n",
       "    \n",
       "\n",
       "    \n",
       "    80 individuals had disease onset information\n",
       "    and 5 had information about the age of last encounter.\n",
       "  </p>\n",
       "\n",
       "  \n",
       "  <p>No errors encountered.</p>\n",
       "  \n",
       "</div>\n",
       "\n",
       "\n",
       "<div class=\"cards\">\n",
       "  \n",
       "  <div id=\"hpo\" class=\"card\">\n",
       "    <h2>HPO terms</h2>\n",
       "    \n",
       "    \n",
       "    <table>\n",
       "      The cohort included 66 distinct HPO terms.\n",
       "      <caption>\n",
       "        \n",
       "        Top 10 most common HPO terms.\n",
       "        \n",
       "        \n",
       "      </caption>\n",
       "      <tbody>\n",
       "        <tr class=\"strng\">\n",
       "          <th><em>n</em></th>\n",
       "          <th>HPO Term</th>\n",
       "        </tr>\n",
       "\n",
       "        \n",
       "        <tr>\n",
       "          <td>61</td>\n",
       "          <td><a href=\"https://hpo.jax.org/browse/term/HP:0010976\">B lymphocytopenia</a>\n",
       "          </td>\n",
       "        </tr>\n",
       "        \n",
       "        <tr>\n",
       "          <td>50</td>\n",
       "          <td><a href=\"https://hpo.jax.org/browse/term/HP:0002720\">Decreased circulating IgA concentration</a>\n",
       "          </td>\n",
       "        </tr>\n",
       "        \n",
       "        <tr>\n",
       "          <td>49</td>\n",
       "          <td><a href=\"https://hpo.jax.org/browse/term/HP:0002850\">Decreased circulating total IgM</a>\n",
       "          </td>\n",
       "        </tr>\n",
       "        \n",
       "        <tr>\n",
       "          <td>46</td>\n",
       "          <td><a href=\"https://hpo.jax.org/browse/term/HP:0004315\">Decreased circulating IgG concentration</a>\n",
       "          </td>\n",
       "        </tr>\n",
       "        \n",
       "        <tr>\n",
       "          <td>29</td>\n",
       "          <td><a href=\"https://hpo.jax.org/browse/term/HP:0033222\">Decreased CD4:CD8 ratio</a>\n",
       "          </td>\n",
       "        </tr>\n",
       "        \n",
       "        <tr>\n",
       "          <td>22</td>\n",
       "          <td><a href=\"https://hpo.jax.org/browse/term/HP:0030374\">Decreased proportion of memory B cells</a>\n",
       "          </td>\n",
       "        </tr>\n",
       "        \n",
       "        <tr>\n",
       "          <td>17</td>\n",
       "          <td><a href=\"https://hpo.jax.org/browse/term/HP:0002719\">Recurrent infections</a>\n",
       "          </td>\n",
       "        </tr>\n",
       "        \n",
       "        <tr>\n",
       "          <td>16</td>\n",
       "          <td><a href=\"https://hpo.jax.org/browse/term/HP:0032218\">Decreased proportion of CD4-positive T cells</a>\n",
       "          </td>\n",
       "        </tr>\n",
       "        \n",
       "        <tr>\n",
       "          <td>14</td>\n",
       "          <td><a href=\"https://hpo.jax.org/browse/term/HP:0006532\">Recurrent pneumonia</a>\n",
       "          </td>\n",
       "        </tr>\n",
       "        \n",
       "        <tr>\n",
       "          <td>14</td>\n",
       "          <td><a href=\"https://hpo.jax.org/browse/term/HP:0020102\">Pneumocystis jirovecii pneumonia</a>\n",
       "          </td>\n",
       "        </tr>\n",
       "        \n",
       "      </tbody>\n",
       "    </table>\n",
       "    \n",
       "    \n",
       "  </div>\n",
       "\n",
       "  \n",
       "  <div id=\"measurements\" class=\"card\">\n",
       "    <h2>Measurements</h2>\n",
       "    \n",
       "    \n",
       "    No data regarding measurement assays were provided.\n",
       "    \n",
       "  </div>\n",
       "\n",
       "  \n",
       "  <div id=\"diseases\" class=\"card\">\n",
       "    <h2>Diseases</h2>\n",
       "    \n",
       "    \n",
       "    The cohort members were diagnosed with 1 disease.\n",
       "    <table>\n",
       "      \n",
       "\n",
       "      <tbody>\n",
       "        <tr class=\"strng\">\n",
       "          <th><em>n</em></th>\n",
       "          <th>Disease</th>\n",
       "        </tr>\n",
       "        \n",
       "        <tr>\n",
       "          <td>82</td>\n",
       "          <td><a href=\"https://hpo.jax.org/browse/disease/OMIM:616873\">Immunodeficiency, common variable, 13</a>\n",
       "          </td>\n",
       "        </tr>\n",
       "        \n",
       "      </tbody>\n",
       "    </table>\n",
       "    \n",
       "  </div>\n",
       "\n",
       "  \n",
       "  \n",
       "  <div class=\"card\">\n",
       "    <h2>Variants</h2>\n",
       "    <p>\n",
       "      A total of 26 unique variants\n",
       "      were identified in the cohort. Variants were annotated with respect to NM_006060.6.\n",
       "    </p>\n",
       "    <table>\n",
       "      <caption>\n",
       "        <h3>Top 10 variants</h3>\n",
       "      </caption>\n",
       "      <tbody>\n",
       "        <tr class=\"strng\">\n",
       "          <th><em>n</em></th>\n",
       "          <th>Variant key</th>\n",
       "          <th>HGVS</th>\n",
       "          <th>Variant Class</th>\n",
       "        </tr>\n",
       "        \n",
       "        <tr>\n",
       "          <td>15</td>\n",
       "          <td>SO:1000029_HGNC:13176_IKZF1</td>\n",
       "          <td>1000029_HGNC (None)</td>\n",
       "          <td>TRANSCRIPT_ABLATION</td>\n",
       "        </tr>\n",
       "        \n",
       "        <tr>\n",
       "          <td>13</td>\n",
       "          <td>7_50382594_50382594_A_G</td>\n",
       "          <td>c.476A>G (p.Asn159Ser)</td>\n",
       "          <td>MISSENSE_VARIANT</td>\n",
       "        </tr>\n",
       "        \n",
       "        <tr>\n",
       "          <td>12</td>\n",
       "          <td>7_50382603_50382603_G_A</td>\n",
       "          <td>c.485G>A (p.Arg162Gln)</td>\n",
       "          <td>MISSENSE_VARIANT</td>\n",
       "        </tr>\n",
       "        \n",
       "        <tr>\n",
       "          <td>5</td>\n",
       "          <td>7_50382545_50382545_C_T</td>\n",
       "          <td>c.427C>T (p.Arg143Trp)</td>\n",
       "          <td>MISSENSE_VARIANT</td>\n",
       "        </tr>\n",
       "        \n",
       "        <tr>\n",
       "          <td>4</td>\n",
       "          <td>7_50382618_50382618_A_G</td>\n",
       "          <td>c.500A>G (p.His167Arg)</td>\n",
       "          <td>MISSENSE_VARIANT</td>\n",
       "        </tr>\n",
       "        \n",
       "        <tr>\n",
       "          <td>3</td>\n",
       "          <td>7_50382602_50382602_C_T</td>\n",
       "          <td>c.484C>T (p.Arg162Trp)</td>\n",
       "          <td>MISSENSE_VARIANT</td>\n",
       "        </tr>\n",
       "        \n",
       "        <tr>\n",
       "          <td>3</td>\n",
       "          <td>7_50382702_50382702_A_G</td>\n",
       "          <td>c.584A>G (p.His195Arg)</td>\n",
       "          <td>MISSENSE_VARIANT</td>\n",
       "        </tr>\n",
       "        \n",
       "        <tr>\n",
       "          <td>3</td>\n",
       "          <td>7_50327730_50327731_CA_C</td>\n",
       "          <td>c.136del (p.Ser46AlafsTer14)</td>\n",
       "          <td>FRAMESHIFT_VARIANT</td>\n",
       "        </tr>\n",
       "        \n",
       "        <tr>\n",
       "          <td>2</td>\n",
       "          <td>7_50382603_50382603_G_T</td>\n",
       "          <td>c.485G>T (p.Arg162Leu)</td>\n",
       "          <td>MISSENSE_VARIANT</td>\n",
       "        </tr>\n",
       "        \n",
       "        <tr>\n",
       "          <td>2</td>\n",
       "          <td>7_50400076_50400076_G_A</td>\n",
       "          <td>c.1009G>A (p.Gly337Ser)</td>\n",
       "          <td>MISSENSE_VARIANT</td>\n",
       "        </tr>\n",
       "        \n",
       "      </tbody>\n",
       "    </table>\n",
       "  </div>\n",
       "\n",
       "  \n",
       "  <div class=\"card\">\n",
       "    \n",
       "    <h2>Variant effects</h2>\n",
       "    <p>\n",
       "      The effects were predicted for NM_006060.6\n",
       "    </p>\n",
       "    <table>\n",
       "      <tbody>\n",
       "        <tr class=\"strng\">\n",
       "          <th>Variant effect</th>\n",
       "          <th>Count</th>\n",
       "        </tr>\n",
       "        \n",
       "        <tr>\n",
       "          <td>MISSENSE_VARIANT</td>\n",
       "          <td>56 (68%)</td>\n",
       "        </tr>\n",
       "        \n",
       "        <tr>\n",
       "          <td>TRANSCRIPT_ABLATION</td>\n",
       "          <td>15 (18%)</td>\n",
       "        </tr>\n",
       "        \n",
       "        <tr>\n",
       "          <td>FRAMESHIFT_VARIANT</td>\n",
       "          <td>5 (6%)</td>\n",
       "        </tr>\n",
       "        \n",
       "        <tr>\n",
       "          <td>INTRON_VARIANT</td>\n",
       "          <td>2 (2%)</td>\n",
       "        </tr>\n",
       "        \n",
       "        <tr>\n",
       "          <td>STOP_GAINED</td>\n",
       "          <td>2 (2%)</td>\n",
       "        </tr>\n",
       "        \n",
       "        <tr>\n",
       "          <td>SPLICE_DONOR_VARIANT</td>\n",
       "          <td>2 (2%)</td>\n",
       "        </tr>\n",
       "        \n",
       "      </tbody>\n",
       "    </table>\n",
       "    \n",
       "  </div>\n",
       "</div>\n",
       "\n",
       "    </div>\n",
       "</div>"
      ],
      "text/plain": [
       "<gpsea.view._base.HtmlGpseaReport at 0x7d2535f77740>"
      ]
     },
     "execution_count": 4,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "from gpsea.view import CohortViewer\n",
    "cv = CohortViewer(hpo=hpo)\n",
    "cv.process(cohort=cohort, transcript_id=mane_tx_id)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1500x800 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "from gpsea.view import ProteinVisualizer\n",
    "import matplotlib.pyplot as plt\n",
    "\n",
    "IKZF1_fig, ax = plt.subplots(figsize=(15, 8))\n",
    "visualizer = ProteinVisualizer()\n",
    "visualizer.draw_protein(\n",
    "    protein_metadata=protein_meta,\n",
    "    cohort=cohort,\n",
    "    ax=ax,\n",
    ")\n",
    "IKZF1_fig.tight_layout()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "    <style>\n",
       "        /** Light theme is the default */\n",
       "        :root {\n",
       "            --gpsea-color-text: black;\n",
       "            --gpsea-color-link-text: rgb(0, 118, 187);\n",
       "            --gpsea-color-link-hover: rgb(0, 99, 156);\n",
       "            --gpsea-color-primary-a0: #2f5170;\n",
       "            --gpsea-color-primary-a10: #4778a5;\n",
       "            --gpsea-color-primary-a20: #5995ce;\n",
       "            --gpsea-color-primary-a60: LightSkyBlue;\n",
       "            --gpsea-color-surface-a0: #fcfcfc;\n",
       "            --gpsea-color-surface-a10: #ffffff;\n",
       "            --gpsea-color-surface-a20: #b3b3b3;\n",
       "            --gpsea-color-surface-a30: #8d8d8d;\n",
       "            --gpsea-color-surface-a40: #646464;\n",
       "            --gpsea-color-surface-a50: #000000;\n",
       "        }\n",
       "\n",
       "        /** Dark theme */\n",
       "        /*\n",
       "        @media (prefers-color-scheme: dark) {\n",
       "            :root {\n",
       "                --gpsea-color-text: rgb(240, 240, 240);\n",
       "                --gpsea-color-link-text: rgb(240, 240, 240);\n",
       "                --gpsea-color-link-hover: lightblue;\n",
       "                --gpsea-color-primary-a0: #64a3df;\n",
       "                --gpsea-color-primary-a10: #5286b8;\n",
       "                --gpsea-color-primary-a20: #375c7e;\n",
       "                --gpsea-color-primary-a60: #233b52;\n",
       "                --gpsea-color-surface-a0: #121212;\n",
       "                --gpsea-color-surface-a10: #282828;\n",
       "                --gpsea-color-surface-a20: #3f3f3f;\n",
       "                --gpsea-color-surface-a30: #575757;\n",
       "                --gpsea-color-surface-a40: #717171;\n",
       "                --gpsea-color-surface-a50: #8b8b8b;\n",
       "            }\n",
       "        }\n",
       "        */\n",
       "\n",
       "        #gpsea-body {\n",
       "            max-width: 1600px;\n",
       "            color: var(--gpsea-color-text);\n",
       "            background-color: var(--gpsea-color-surface-a0);\n",
       "            padding: 10px 0;\n",
       "        }\n",
       "\n",
       "        #gpsea-body {\n",
       "\n",
       "            h1,\n",
       "            h2,\n",
       "            h3,\n",
       "            h4,\n",
       "            h5 {\n",
       "                color: var(--gpsea-color-primary-a0);\n",
       "            }\n",
       "\n",
       "            a {\n",
       "                color: var(--gpsea-color-link-text);\n",
       "                text-decoration: none;\n",
       "            }\n",
       "\n",
       "            a:hover {\n",
       "                color: var(--gpsea-color-link-hover);\n",
       "            }\n",
       "\n",
       "            #cohort-summary {\n",
       "                max-width: 800px;\n",
       "            }\n",
       "\n",
       "            td {\n",
       "                padding: 5px 0;\n",
       "            }\n",
       "\n",
       "            .cards {\n",
       "                display: flex;\n",
       "                flex-flow: row wrap;\n",
       "                align-items: top;\n",
       "                gap: 1rem;\n",
       "            }\n",
       "\n",
       "            .card {\n",
       "                border-radius: 5px;\n",
       "                padding: 0px 10px;\n",
       "                background: var(--gpsea-color-surface-a10);\n",
       "                border: 1px solid var(--gpsea-color-surface-a30);\n",
       "                box-shadow: 0 4px 8px var(--gpsea-color-surface-a30);\n",
       "            }\n",
       "\n",
       "            table {\n",
       "                width: 100%;\n",
       "                border-collapse: collapse;\n",
       "                margin: 10px 0;\n",
       "                font-size: 0.9em;\n",
       "                font-family: sans-serif;\n",
       "                box-shadow: 0 0 20px rgba(0, 0, 0, 0.15);\n",
       "                border: 1px solid var(--gpsea-color-primary-a60);\n",
       "            }\n",
       "\n",
       "            th {\n",
       "                text-align: left;\n",
       "                padding: 2px;\n",
       "                font-weight: bold;\n",
       "                font-size: 120%;\n",
       "                color: var(--gpsea-color-text);\n",
       "                background-color: var(--gpsea-color-primary-a60);\n",
       "            }\n",
       "\n",
       "            table td,\n",
       "            tr {\n",
       "                text-align: left;\n",
       "                padding: 0px 5px;\n",
       "            }\n",
       "\n",
       "            tr:nth-child(even) {\n",
       "                background-color: var(--gpsea-color-surface-a10);\n",
       "            }\n",
       "\n",
       "            tr:nth-child(odd) {\n",
       "                background-color: var(--gpsea-color-surface-a20);\n",
       "            }\n",
       "\n",
       "            caption {\n",
       "                caption-side: top;\n",
       "                text-align: left;\n",
       "                padding-bottom: 10px;\n",
       "                font-weight: bold;\n",
       "            }\n",
       "        }\n",
       "    </style>\n",
       "    <div id=\"gpsea-body\">\n",
       "        \n",
       "<h1>DNA-binding protein Ikaros: NP_006051.1</h1>\n",
       "<div class=\"card\">\n",
       "  <p>\n",
       "    DNA-binding protein Ikaros has 11 annotated protein featureses.\n",
       "    54 were found to be located within these features,\n",
       "    and 9 were located elsewhere.\n",
       "    The total length of the protein is 519 amino acid residues.\n",
       "  </p>\n",
       "  <table>\n",
       "    <tbody>\n",
       "        <tr>\n",
       "          <th>Count</th>\n",
       "          <th>Name</th>\n",
       "          <th>Type</th>\n",
       "          <th>Coordinates</th>\n",
       "          <th>Variants</th>\n",
       "        </tr>\n",
       "        \n",
       "        <tr>\n",
       "          <td>3</td>\n",
       "          <td>Disordered</td>\n",
       "          <td>Region</td>\n",
       "          <td>2 - 72</td>\n",
       "          <td>p.Ser46AlafsTer14</td>\n",
       "        </tr>\n",
       "        \n",
       "        <tr>\n",
       "          <td>0</td>\n",
       "          <td>C2H2-type 1</td>\n",
       "          <td>Zinc finger</td>\n",
       "          <td>118 - 139</td>\n",
       "          <td></td>\n",
       "        </tr>\n",
       "        \n",
       "        <tr>\n",
       "          <td>40</td>\n",
       "          <td>C2H2-type 2</td>\n",
       "          <td>Zinc finger</td>\n",
       "          <td>146 - 167</td>\n",
       "          <td>p.Arg162Gln; p.Asn159Thr; p.His167Tyr; p.Cys147Arg; p.Asn159Ser; p.Cys150Arg; p.His163SerfsTer32; p.Arg162Leu; p.Arg162Trp; p.His167Arg</td>\n",
       "        </tr>\n",
       "        \n",
       "        <tr>\n",
       "          <td>32</td>\n",
       "          <td>Required for both high-affinity DNA binding and pericentromeric heterochromatin localization</td>\n",
       "          <td>Region</td>\n",
       "          <td>155 - 163</td>\n",
       "          <td>p.Arg162Gln; p.Asn159Thr; p.Asn159Ser; p.His163SerfsTer32; p.Arg162Trp; p.Arg162Leu</td>\n",
       "        </tr>\n",
       "        \n",
       "        <tr>\n",
       "          <td>6</td>\n",
       "          <td>C2H2-type 3</td>\n",
       "          <td>Zinc finger</td>\n",
       "          <td>174 - 195</td>\n",
       "          <td>p.Cys182Ter; p.His195Arg; p.Arg184Gln</td>\n",
       "        </tr>\n",
       "        \n",
       "        <tr>\n",
       "          <td>6</td>\n",
       "          <td>Required for both high-affinity DNA binding and pericentromeric heterochromatin localization</td>\n",
       "          <td>Region</td>\n",
       "          <td>181 - 195</td>\n",
       "          <td>p.Cys182Ter; p.His195Arg; p.Arg184Gln</td>\n",
       "        </tr>\n",
       "        \n",
       "        <tr>\n",
       "          <td>2</td>\n",
       "          <td>C2H2-type 4</td>\n",
       "          <td>Zinc finger</td>\n",
       "          <td>202 - 224</td>\n",
       "          <td>p.Tyr210Cys</td>\n",
       "        </tr>\n",
       "        \n",
       "        <tr>\n",
       "          <td>0</td>\n",
       "          <td>Disordered</td>\n",
       "          <td>Region</td>\n",
       "          <td>382 - 406</td>\n",
       "          <td></td>\n",
       "        </tr>\n",
       "        \n",
       "        <tr>\n",
       "          <td>1</td>\n",
       "          <td>C2H2-type 5</td>\n",
       "          <td>Zinc finger</td>\n",
       "          <td>463 - 484</td>\n",
       "          <td>p.Cys467Trp</td>\n",
       "        </tr>\n",
       "        \n",
       "        <tr>\n",
       "          <td>0</td>\n",
       "          <td>Required for binding PP1CC</td>\n",
       "          <td>Region</td>\n",
       "          <td>469 - 471</td>\n",
       "          <td></td>\n",
       "        </tr>\n",
       "        \n",
       "        <tr>\n",
       "          <td>2</td>\n",
       "          <td>C2H2-type 6</td>\n",
       "          <td>Zinc finger</td>\n",
       "          <td>491 - 514</td>\n",
       "          <td>p.Met494ValfsTer86; p.Met494Val</td>\n",
       "        </tr>\n",
       "        \n",
       "    </tbody>\n",
       "</table>\n",
       "</div>\n",
       "\n",
       "    </div>\n",
       "</div>"
      ],
      "text/plain": [
       "<gpsea.view._base.HtmlGpseaReport at 0x7d2533b96420>"
      ]
     },
     "execution_count": 6,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "from gpsea.view import ProteinVariantViewer\n",
    "pvv = ProteinVariantViewer(protein_metadata=protein_meta, tx_id=mane_tx_id)\n",
    "pvv.process(cohort=cohort)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Genotype-Phenotype Correlation (GPC) Analysis"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {},
   "outputs": [],
   "source": [
    "from gpsea.analysis.clf import prepare_classifiers_for_terms_of_interest\n",
    "from gpsea.analysis.pcats import configure_hpo_term_analysis\n",
    "analysis = configure_hpo_term_analysis(hpo)\n",
    "\n",
    "pheno_clfs = prepare_classifiers_for_terms_of_interest(\n",
    "    cohort=cohort,\n",
    "    hpo=hpo,\n",
    ")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "    <style>\n",
       "        /** Light theme is the default */\n",
       "        :root {\n",
       "            --gpsea-color-text: black;\n",
       "            --gpsea-color-link-text: rgb(0, 118, 187);\n",
       "            --gpsea-color-link-hover: rgb(0, 99, 156);\n",
       "            --gpsea-color-primary-a0: #2f5170;\n",
       "            --gpsea-color-primary-a10: #4778a5;\n",
       "            --gpsea-color-primary-a20: #5995ce;\n",
       "            --gpsea-color-primary-a60: LightSkyBlue;\n",
       "            --gpsea-color-surface-a0: #fcfcfc;\n",
       "            --gpsea-color-surface-a10: #ffffff;\n",
       "            --gpsea-color-surface-a20: #b3b3b3;\n",
       "            --gpsea-color-surface-a30: #8d8d8d;\n",
       "            --gpsea-color-surface-a40: #646464;\n",
       "            --gpsea-color-surface-a50: #000000;\n",
       "        }\n",
       "\n",
       "        /** Dark theme */\n",
       "        /*\n",
       "        @media (prefers-color-scheme: dark) {\n",
       "            :root {\n",
       "                --gpsea-color-text: rgb(240, 240, 240);\n",
       "                --gpsea-color-link-text: rgb(240, 240, 240);\n",
       "                --gpsea-color-link-hover: lightblue;\n",
       "                --gpsea-color-primary-a0: #64a3df;\n",
       "                --gpsea-color-primary-a10: #5286b8;\n",
       "                --gpsea-color-primary-a20: #375c7e;\n",
       "                --gpsea-color-primary-a60: #233b52;\n",
       "                --gpsea-color-surface-a0: #121212;\n",
       "                --gpsea-color-surface-a10: #282828;\n",
       "                --gpsea-color-surface-a20: #3f3f3f;\n",
       "                --gpsea-color-surface-a30: #575757;\n",
       "                --gpsea-color-surface-a40: #717171;\n",
       "                --gpsea-color-surface-a50: #8b8b8b;\n",
       "            }\n",
       "        }\n",
       "        */\n",
       "\n",
       "        #gpsea-body {\n",
       "            max-width: 1600px;\n",
       "            color: var(--gpsea-color-text);\n",
       "            background-color: var(--gpsea-color-surface-a0);\n",
       "            padding: 10px 0;\n",
       "        }\n",
       "\n",
       "        #gpsea-body {\n",
       "\n",
       "            h1,\n",
       "            h2,\n",
       "            h3,\n",
       "            h4,\n",
       "            h5 {\n",
       "                color: var(--gpsea-color-primary-a0);\n",
       "            }\n",
       "\n",
       "            a {\n",
       "                color: var(--gpsea-color-link-text);\n",
       "                text-decoration: none;\n",
       "            }\n",
       "\n",
       "            a:hover {\n",
       "                color: var(--gpsea-color-link-hover);\n",
       "            }\n",
       "\n",
       "            #cohort-summary {\n",
       "                max-width: 800px;\n",
       "            }\n",
       "\n",
       "            td {\n",
       "                padding: 5px 0;\n",
       "            }\n",
       "\n",
       "            .cards {\n",
       "                display: flex;\n",
       "                flex-flow: row wrap;\n",
       "                align-items: top;\n",
       "                gap: 1rem;\n",
       "            }\n",
       "\n",
       "            .card {\n",
       "                border-radius: 5px;\n",
       "                padding: 0px 10px;\n",
       "                background: var(--gpsea-color-surface-a10);\n",
       "                border: 1px solid var(--gpsea-color-surface-a30);\n",
       "                box-shadow: 0 4px 8px var(--gpsea-color-surface-a30);\n",
       "            }\n",
       "\n",
       "            table {\n",
       "                width: 100%;\n",
       "                border-collapse: collapse;\n",
       "                margin: 10px 0;\n",
       "                font-size: 0.9em;\n",
       "                font-family: sans-serif;\n",
       "                box-shadow: 0 0 20px rgba(0, 0, 0, 0.15);\n",
       "                border: 1px solid var(--gpsea-color-primary-a60);\n",
       "            }\n",
       "\n",
       "            th {\n",
       "                text-align: left;\n",
       "                padding: 2px;\n",
       "                font-weight: bold;\n",
       "                font-size: 120%;\n",
       "                color: var(--gpsea-color-text);\n",
       "                background-color: var(--gpsea-color-primary-a60);\n",
       "            }\n",
       "\n",
       "            table td,\n",
       "            tr {\n",
       "                text-align: left;\n",
       "                padding: 0px 5px;\n",
       "            }\n",
       "\n",
       "            tr:nth-child(even) {\n",
       "                background-color: var(--gpsea-color-surface-a10);\n",
       "            }\n",
       "\n",
       "            tr:nth-child(odd) {\n",
       "                background-color: var(--gpsea-color-surface-a20);\n",
       "            }\n",
       "\n",
       "            caption {\n",
       "                caption-side: top;\n",
       "                text-align: left;\n",
       "                padding-bottom: 10px;\n",
       "                font-weight: bold;\n",
       "            }\n",
       "        }\n",
       "    </style>\n",
       "    <div id=\"gpsea-body\">\n",
       "        \n",
       "<h1>Phenotype testing report</h1>\n",
       "<div class=\"cards\">\n",
       "  <div class=\"card\">\n",
       "    <ul>\n",
       "      <li>Phenotype MTC filter: <em>Independent filtering HPO filter</em></li>\n",
       "      <li>Multiple testing correction: <em>fdr_bh</em></li>\n",
       "    </ul>\n",
       "  </div>\n",
       "  <div class=\"card\">\n",
       "    <table>\n",
       "      <tbody>\n",
       "        <tr>\n",
       "          <th>Reason</th>\n",
       "          <th>Count</th>\n",
       "        </tr>\n",
       "        \n",
       "        <tr>\n",
       "          \n",
       "            <td><a href=\"https://P2GX.github.io/gpsea/stable/user-guide/analyses/mtc.html#skip-terms-if-all-counts-are-identical-to-counts-for-a-child-term\">Skip terms if all counts are identical to counts for a child term</a></td>\n",
       "          \n",
       "          <td>3</td>\n",
       "        </tr>\n",
       "        \n",
       "        <tr>\n",
       "          \n",
       "            <td><a href=\"https://P2GX.github.io/gpsea/stable/user-guide/analyses/mtc.html#skip-term-if-one-of-the-genotype-groups-has-neither-observed-nor-excluded-observations\">Skipping term because one genotype had zero observations</a></td>\n",
       "          \n",
       "          <td>5</td>\n",
       "        </tr>\n",
       "        \n",
       "        <tr>\n",
       "          \n",
       "            <td><a href=\"https://P2GX.github.io/gpsea/stable/user-guide/analyses/mtc.html#skipping-general-level-terms\">Skipping \"general\" level terms</a></td>\n",
       "          \n",
       "          <td>59</td>\n",
       "        </tr>\n",
       "        \n",
       "        <tr>\n",
       "          \n",
       "            <td><a href=\"https://P2GX.github.io/gpsea/stable/user-guide/analyses/mtc.html#skipping-terms-that-are-rare-on-the-cohort-level\">Skipping terms that are rare on the cohort level (in less than 40% of the cohort members)</a></td>\n",
       "          \n",
       "          <td>120</td>\n",
       "        </tr>\n",
       "        \n",
       "      </tbody>\n",
       "      <caption>\n",
       "        Performed statistical tests for 29 out of the total of 216 HPO terms.\n",
       "      </caption>\n",
       "    </table>\n",
       "  </div>\n",
       "</div>\n",
       "\n",
       "    </div>\n",
       "</div>"
      ],
      "text/plain": [
       "<gpsea.view._base.HtmlGpseaReport at 0x7d2533ae9f40>"
      ]
     },
     "execution_count": 8,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "from gpsea.analysis.predicate import variant_key\n",
    "from gpsea.analysis.clf import monoallelic_classifier\n",
    "from gpsea.view import MtcStatsViewer\n",
    "\n",
    "asn159ser = variant_key(\"7_50382594_50382594_A_G\") # p.Asn159Ser\t\n",
    "asn159ser_clf = monoallelic_classifier(\n",
    "    a_predicate=asn159ser,\n",
    "    b_predicate= ~asn159ser,\n",
    "    a_label='p.Asn159Ser',\n",
    "    b_label='Other variant'\n",
    ")\n",
    "\n",
    "asn159ser_result = analysis.compare_genotype_vs_phenotypes(\n",
    "    cohort=cohort,\n",
    "    gt_clf=asn159ser_clf,\n",
    "    pheno_clfs=pheno_clfs,\n",
    ")\n",
    "viewer = MtcStatsViewer()\n",
    "viewer.process(asn159ser_result)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "application/vnd.microsoft.datawrangler.viewer.v0+json": {
       "columns": [
        {
         "name": "index",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "p.Asn159Ser",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "Other variant",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "Corrected p values",
         "rawType": "float64",
         "type": "float"
        },
        {
         "name": "p values",
         "rawType": "float64",
         "type": "float"
        }
       ],
       "conversionMethod": "pd.DataFrame",
       "ref": "579b2012-8964-4562-b410-070a8e48a8b5",
       "rows": [
        [
         "Recurrent pneumonia [HP:0006532]",
         "7/9 (78%)",
         "7/39 (18%)",
         "0.03509271419973629",
         "0.0012100935930943546"
        ],
        [
         "T-cell acute lymphoblastic leukemias [HP:0006727]",
         "3/13 (23%)",
         "0/69 (0%)",
         "0.046827009936766036",
         "0.0032294489611562785"
        ],
        [
         "Recurrent otitis media [HP:0000403]",
         "3/6 (50%)",
         "7/48 (15%)",
         "0.5514363896785475",
         "0.06966455667898509"
        ],
        [
         "Decreased circulating total IgM [HP:0002850]",
         "9/9 (100%)",
         "40/56 (71%)",
         "0.5514363896785475",
         "0.09827601854405349"
        ],
        [
         "Recurrent sinusitis [HP:0011108]",
         "1/1 (100%)",
         "5/50 (10%)",
         "0.5514363896785475",
         "0.11764705882352942"
        ],
        [
         "Decreased CD4:CD8 ratio [HP:0033222]",
         "1/7 (14%)",
         "28/59 (47%)",
         "0.5514363896785475",
         "0.12436060766309312"
        ],
        [
         "Chronic diarrhea [HP:0002028]",
         "1/1 (100%)",
         "6/49 (12%)",
         "0.5514363896785475",
         "0.14"
        ],
        [
         "Decreased circulating IgG concentration [HP:0004315]",
         "8/8 (100%)",
         "38/51 (75%)",
         "0.5514363896785475",
         "0.17993604480307437"
        ],
        [
         "Decreased circulating IgA concentration [HP:0002720]",
         "9/9 (100%)",
         "41/54 (76%)",
         "0.5514363896785475",
         "0.183902357983476"
        ],
        [
         "B lymphocytopenia [HP:0010976]",
         "13/13 (100%)",
         "48/58 (83%)",
         "0.5514363896785475",
         "0.19015047919949912"
        ],
        [
         "Recurrent bacterial skin infections [HP:0005406]",
         "1/6 (17%)",
         "2/37 (5%)",
         "0.9753098561959542",
         "0.37039137833238794"
        ],
        [
         "Increased proportion of CD4-positive T cells [HP:0032219]",
         "4/10 (40%)",
         "6/28 (21%)",
         "0.9753098561959542",
         "0.40357649221901554"
        ],
        [
         "B Acute Lymphoblastic Leukemia [HP:0004812]",
         "0/13 (0%)",
         "3/69 (4%)",
         "1.0",
         "1.0"
        ],
        [
         "Autoimmune thrombocytopenia [HP:0001973]",
         "0/2 (0%)",
         "6/56 (11%)",
         "1.0",
         "1.0"
        ],
        [
         "Recurrent infections [HP:0002719]",
         "11/11 (100%)",
         "41/41 (100%)",
         "1.0",
         "1.0"
        ],
        [
         "Unusual infection [HP:0032101]",
         "13/13 (100%)",
         "42/42 (100%)",
         "1.0",
         "1.0"
        ],
        [
         "Lymphopenia [HP:0001888]",
         "13/13 (100%)",
         "48/48 (100%)",
         "1.0",
         "1.0"
        ],
        [
         "Abnormal circulating immunoglobulin concentration [HP:0010701]",
         "13/13 (100%)",
         "56/56 (100%)",
         "1.0",
         "1.0"
        ],
        [
         "Decreased circulating antibody concentration [HP:0004313]",
         "13/13 (100%)",
         "56/56 (100%)",
         "1.0",
         "1.0"
        ],
        [
         "Abnormal B cell count [HP:0010975]",
         "13/13 (100%)",
         "57/57 (100%)",
         "1.0",
         "1.0"
        ],
        [
         "Abnormal lymphocyte count [HP:0040088]",
         "13/13 (100%)",
         "60/60 (100%)",
         "1.0",
         "1.0"
        ],
        [
         "Abnormal B cell subset distribution [HP:0025539]",
         "2/2 (100%)",
         "33/33 (100%)",
         "1.0",
         "1.0"
        ],
        [
         "Decreased proportion of CD4-positive T cells [HP:0032218]",
         "4/10 (40%)",
         "12/33 (36%)",
         "1.0",
         "1.0"
        ],
        [
         "Abnormal T cell subset distribution [HP:0025540]",
         "8/8 (100%)",
         "34/34 (100%)",
         "1.0",
         "1.0"
        ],
        [
         "Abnormal T cell count [HP:0011839]",
         "8/8 (100%)",
         "35/35 (100%)",
         "1.0",
         "1.0"
        ],
        [
         "Abnormal circulating IgG concentration [HP:0410242]",
         "8/8 (100%)",
         "38/38 (100%)",
         "1.0",
         "1.0"
        ],
        [
         "Recurrent respiratory infections [HP:0002205]",
         "9/9 (100%)",
         "23/25 (92%)",
         "1.0",
         "1.0"
        ],
        [
         "Abnormal circulating IgM concentration [HP:0410243]",
         "9/9 (100%)",
         "40/40 (100%)",
         "1.0",
         "1.0"
        ],
        [
         "Abnormal circulating IgA concentration [HP:0410240]",
         "9/9 (100%)",
         "41/41 (100%)",
         "1.0",
         "1.0"
        ]
       ],
       "shape": {
        "columns": 4,
        "rows": 29
       }
      },
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th>Allele group</th>\n",
       "      <th>p.Asn159Ser</th>\n",
       "      <th>Other variant</th>\n",
       "      <th>Corrected p values</th>\n",
       "      <th>p values</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>Recurrent pneumonia [HP:0006532]</th>\n",
       "      <td>7/9 (78%)</td>\n",
       "      <td>7/39 (18%)</td>\n",
       "      <td>0.035093</td>\n",
       "      <td>0.001210</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>T-cell acute lymphoblastic leukemias [HP:0006727]</th>\n",
       "      <td>3/13 (23%)</td>\n",
       "      <td>0/69 (0%)</td>\n",
       "      <td>0.046827</td>\n",
       "      <td>0.003229</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Recurrent otitis media [HP:0000403]</th>\n",
       "      <td>3/6 (50%)</td>\n",
       "      <td>7/48 (15%)</td>\n",
       "      <td>0.551436</td>\n",
       "      <td>0.069665</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Decreased circulating total IgM [HP:0002850]</th>\n",
       "      <td>9/9 (100%)</td>\n",
       "      <td>40/56 (71%)</td>\n",
       "      <td>0.551436</td>\n",
       "      <td>0.098276</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Recurrent sinusitis [HP:0011108]</th>\n",
       "      <td>1/1 (100%)</td>\n",
       "      <td>5/50 (10%)</td>\n",
       "      <td>0.551436</td>\n",
       "      <td>0.117647</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Decreased CD4:CD8 ratio [HP:0033222]</th>\n",
       "      <td>1/7 (14%)</td>\n",
       "      <td>28/59 (47%)</td>\n",
       "      <td>0.551436</td>\n",
       "      <td>0.124361</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Chronic diarrhea [HP:0002028]</th>\n",
       "      <td>1/1 (100%)</td>\n",
       "      <td>6/49 (12%)</td>\n",
       "      <td>0.551436</td>\n",
       "      <td>0.140000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Decreased circulating IgG concentration [HP:0004315]</th>\n",
       "      <td>8/8 (100%)</td>\n",
       "      <td>38/51 (75%)</td>\n",
       "      <td>0.551436</td>\n",
       "      <td>0.179936</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Decreased circulating IgA concentration [HP:0002720]</th>\n",
       "      <td>9/9 (100%)</td>\n",
       "      <td>41/54 (76%)</td>\n",
       "      <td>0.551436</td>\n",
       "      <td>0.183902</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>B lymphocytopenia [HP:0010976]</th>\n",
       "      <td>13/13 (100%)</td>\n",
       "      <td>48/58 (83%)</td>\n",
       "      <td>0.551436</td>\n",
       "      <td>0.190150</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Recurrent bacterial skin infections [HP:0005406]</th>\n",
       "      <td>1/6 (17%)</td>\n",
       "      <td>2/37 (5%)</td>\n",
       "      <td>0.975310</td>\n",
       "      <td>0.370391</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Increased proportion of CD4-positive T cells [HP:0032219]</th>\n",
       "      <td>4/10 (40%)</td>\n",
       "      <td>6/28 (21%)</td>\n",
       "      <td>0.975310</td>\n",
       "      <td>0.403576</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>B Acute Lymphoblastic Leukemia [HP:0004812]</th>\n",
       "      <td>0/13 (0%)</td>\n",
       "      <td>3/69 (4%)</td>\n",
       "      <td>1.000000</td>\n",
       "      <td>1.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Autoimmune thrombocytopenia [HP:0001973]</th>\n",
       "      <td>0/2 (0%)</td>\n",
       "      <td>6/56 (11%)</td>\n",
       "      <td>1.000000</td>\n",
       "      <td>1.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Recurrent infections [HP:0002719]</th>\n",
       "      <td>11/11 (100%)</td>\n",
       "      <td>41/41 (100%)</td>\n",
       "      <td>1.000000</td>\n",
       "      <td>1.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Unusual infection [HP:0032101]</th>\n",
       "      <td>13/13 (100%)</td>\n",
       "      <td>42/42 (100%)</td>\n",
       "      <td>1.000000</td>\n",
       "      <td>1.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Lymphopenia [HP:0001888]</th>\n",
       "      <td>13/13 (100%)</td>\n",
       "      <td>48/48 (100%)</td>\n",
       "      <td>1.000000</td>\n",
       "      <td>1.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Abnormal circulating immunoglobulin concentration [HP:0010701]</th>\n",
       "      <td>13/13 (100%)</td>\n",
       "      <td>56/56 (100%)</td>\n",
       "      <td>1.000000</td>\n",
       "      <td>1.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Decreased circulating antibody concentration [HP:0004313]</th>\n",
       "      <td>13/13 (100%)</td>\n",
       "      <td>56/56 (100%)</td>\n",
       "      <td>1.000000</td>\n",
       "      <td>1.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Abnormal B cell count [HP:0010975]</th>\n",
       "      <td>13/13 (100%)</td>\n",
       "      <td>57/57 (100%)</td>\n",
       "      <td>1.000000</td>\n",
       "      <td>1.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Abnormal lymphocyte count [HP:0040088]</th>\n",
       "      <td>13/13 (100%)</td>\n",
       "      <td>60/60 (100%)</td>\n",
       "      <td>1.000000</td>\n",
       "      <td>1.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Abnormal B cell subset distribution [HP:0025539]</th>\n",
       "      <td>2/2 (100%)</td>\n",
       "      <td>33/33 (100%)</td>\n",
       "      <td>1.000000</td>\n",
       "      <td>1.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Decreased proportion of CD4-positive T cells [HP:0032218]</th>\n",
       "      <td>4/10 (40%)</td>\n",
       "      <td>12/33 (36%)</td>\n",
       "      <td>1.000000</td>\n",
       "      <td>1.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Abnormal T cell subset distribution [HP:0025540]</th>\n",
       "      <td>8/8 (100%)</td>\n",
       "      <td>34/34 (100%)</td>\n",
       "      <td>1.000000</td>\n",
       "      <td>1.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Abnormal T cell count [HP:0011839]</th>\n",
       "      <td>8/8 (100%)</td>\n",
       "      <td>35/35 (100%)</td>\n",
       "      <td>1.000000</td>\n",
       "      <td>1.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Abnormal circulating IgG concentration [HP:0410242]</th>\n",
       "      <td>8/8 (100%)</td>\n",
       "      <td>38/38 (100%)</td>\n",
       "      <td>1.000000</td>\n",
       "      <td>1.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Recurrent respiratory infections [HP:0002205]</th>\n",
       "      <td>9/9 (100%)</td>\n",
       "      <td>23/25 (92%)</td>\n",
       "      <td>1.000000</td>\n",
       "      <td>1.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Abnormal circulating IgM concentration [HP:0410243]</th>\n",
       "      <td>9/9 (100%)</td>\n",
       "      <td>40/40 (100%)</td>\n",
       "      <td>1.000000</td>\n",
       "      <td>1.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Abnormal circulating IgA concentration [HP:0410240]</th>\n",
       "      <td>9/9 (100%)</td>\n",
       "      <td>41/41 (100%)</td>\n",
       "      <td>1.000000</td>\n",
       "      <td>1.000000</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "Allele group                                         p.Asn159Ser  \\\n",
       "Recurrent pneumonia [HP:0006532]                       7/9 (78%)   \n",
       "T-cell acute lymphoblastic leukemias [HP:0006727]     3/13 (23%)   \n",
       "Recurrent otitis media [HP:0000403]                    3/6 (50%)   \n",
       "Decreased circulating total IgM [HP:0002850]          9/9 (100%)   \n",
       "Recurrent sinusitis [HP:0011108]                      1/1 (100%)   \n",
       "Decreased CD4:CD8 ratio [HP:0033222]                   1/7 (14%)   \n",
       "Chronic diarrhea [HP:0002028]                         1/1 (100%)   \n",
       "Decreased circulating IgG concentration [HP:000...    8/8 (100%)   \n",
       "Decreased circulating IgA concentration [HP:000...    9/9 (100%)   \n",
       "B lymphocytopenia [HP:0010976]                      13/13 (100%)   \n",
       "Recurrent bacterial skin infections [HP:0005406]       1/6 (17%)   \n",
       "Increased proportion of CD4-positive T cells [H...    4/10 (40%)   \n",
       "B Acute Lymphoblastic Leukemia [HP:0004812]            0/13 (0%)   \n",
       "Autoimmune thrombocytopenia [HP:0001973]                0/2 (0%)   \n",
       "Recurrent infections [HP:0002719]                   11/11 (100%)   \n",
       "Unusual infection [HP:0032101]                      13/13 (100%)   \n",
       "Lymphopenia [HP:0001888]                            13/13 (100%)   \n",
       "Abnormal circulating immunoglobulin concentrati...  13/13 (100%)   \n",
       "Decreased circulating antibody concentration [H...  13/13 (100%)   \n",
       "Abnormal B cell count [HP:0010975]                  13/13 (100%)   \n",
       "Abnormal lymphocyte count [HP:0040088]              13/13 (100%)   \n",
       "Abnormal B cell subset distribution [HP:0025539]      2/2 (100%)   \n",
       "Decreased proportion of CD4-positive T cells [H...    4/10 (40%)   \n",
       "Abnormal T cell subset distribution [HP:0025540]      8/8 (100%)   \n",
       "Abnormal T cell count [HP:0011839]                    8/8 (100%)   \n",
       "Abnormal circulating IgG concentration [HP:0410...    8/8 (100%)   \n",
       "Recurrent respiratory infections [HP:0002205]         9/9 (100%)   \n",
       "Abnormal circulating IgM concentration [HP:0410...    9/9 (100%)   \n",
       "Abnormal circulating IgA concentration [HP:0410...    9/9 (100%)   \n",
       "\n",
       "Allele group                                       Other variant  \\\n",
       "Recurrent pneumonia [HP:0006532]                      7/39 (18%)   \n",
       "T-cell acute lymphoblastic leukemias [HP:0006727]      0/69 (0%)   \n",
       "Recurrent otitis media [HP:0000403]                   7/48 (15%)   \n",
       "Decreased circulating total IgM [HP:0002850]         40/56 (71%)   \n",
       "Recurrent sinusitis [HP:0011108]                      5/50 (10%)   \n",
       "Decreased CD4:CD8 ratio [HP:0033222]                 28/59 (47%)   \n",
       "Chronic diarrhea [HP:0002028]                         6/49 (12%)   \n",
       "Decreased circulating IgG concentration [HP:000...   38/51 (75%)   \n",
       "Decreased circulating IgA concentration [HP:000...   41/54 (76%)   \n",
       "B lymphocytopenia [HP:0010976]                       48/58 (83%)   \n",
       "Recurrent bacterial skin infections [HP:0005406]       2/37 (5%)   \n",
       "Increased proportion of CD4-positive T cells [H...    6/28 (21%)   \n",
       "B Acute Lymphoblastic Leukemia [HP:0004812]            3/69 (4%)   \n",
       "Autoimmune thrombocytopenia [HP:0001973]              6/56 (11%)   \n",
       "Recurrent infections [HP:0002719]                   41/41 (100%)   \n",
       "Unusual infection [HP:0032101]                      42/42 (100%)   \n",
       "Lymphopenia [HP:0001888]                            48/48 (100%)   \n",
       "Abnormal circulating immunoglobulin concentrati...  56/56 (100%)   \n",
       "Decreased circulating antibody concentration [H...  56/56 (100%)   \n",
       "Abnormal B cell count [HP:0010975]                  57/57 (100%)   \n",
       "Abnormal lymphocyte count [HP:0040088]              60/60 (100%)   \n",
       "Abnormal B cell subset distribution [HP:0025539]    33/33 (100%)   \n",
       "Decreased proportion of CD4-positive T cells [H...   12/33 (36%)   \n",
       "Abnormal T cell subset distribution [HP:0025540]    34/34 (100%)   \n",
       "Abnormal T cell count [HP:0011839]                  35/35 (100%)   \n",
       "Abnormal circulating IgG concentration [HP:0410...  38/38 (100%)   \n",
       "Recurrent respiratory infections [HP:0002205]        23/25 (92%)   \n",
       "Abnormal circulating IgM concentration [HP:0410...  40/40 (100%)   \n",
       "Abnormal circulating IgA concentration [HP:0410...  41/41 (100%)   \n",
       "\n",
       "Allele group                                        Corrected p values  \\\n",
       "Recurrent pneumonia [HP:0006532]                              0.035093   \n",
       "T-cell acute lymphoblastic leukemias [HP:0006727]             0.046827   \n",
       "Recurrent otitis media [HP:0000403]                           0.551436   \n",
       "Decreased circulating total IgM [HP:0002850]                  0.551436   \n",
       "Recurrent sinusitis [HP:0011108]                              0.551436   \n",
       "Decreased CD4:CD8 ratio [HP:0033222]                          0.551436   \n",
       "Chronic diarrhea [HP:0002028]                                 0.551436   \n",
       "Decreased circulating IgG concentration [HP:000...            0.551436   \n",
       "Decreased circulating IgA concentration [HP:000...            0.551436   \n",
       "B lymphocytopenia [HP:0010976]                                0.551436   \n",
       "Recurrent bacterial skin infections [HP:0005406]              0.975310   \n",
       "Increased proportion of CD4-positive T cells [H...            0.975310   \n",
       "B Acute Lymphoblastic Leukemia [HP:0004812]                   1.000000   \n",
       "Autoimmune thrombocytopenia [HP:0001973]                      1.000000   \n",
       "Recurrent infections [HP:0002719]                             1.000000   \n",
       "Unusual infection [HP:0032101]                                1.000000   \n",
       "Lymphopenia [HP:0001888]                                      1.000000   \n",
       "Abnormal circulating immunoglobulin concentrati...            1.000000   \n",
       "Decreased circulating antibody concentration [H...            1.000000   \n",
       "Abnormal B cell count [HP:0010975]                            1.000000   \n",
       "Abnormal lymphocyte count [HP:0040088]                        1.000000   \n",
       "Abnormal B cell subset distribution [HP:0025539]              1.000000   \n",
       "Decreased proportion of CD4-positive T cells [H...            1.000000   \n",
       "Abnormal T cell subset distribution [HP:0025540]              1.000000   \n",
       "Abnormal T cell count [HP:0011839]                            1.000000   \n",
       "Abnormal circulating IgG concentration [HP:0410...            1.000000   \n",
       "Recurrent respiratory infections [HP:0002205]                 1.000000   \n",
       "Abnormal circulating IgM concentration [HP:0410...            1.000000   \n",
       "Abnormal circulating IgA concentration [HP:0410...            1.000000   \n",
       "\n",
       "Allele group                                        p values  \n",
       "Recurrent pneumonia [HP:0006532]                    0.001210  \n",
       "T-cell acute lymphoblastic leukemias [HP:0006727]   0.003229  \n",
       "Recurrent otitis media [HP:0000403]                 0.069665  \n",
       "Decreased circulating total IgM [HP:0002850]        0.098276  \n",
       "Recurrent sinusitis [HP:0011108]                    0.117647  \n",
       "Decreased CD4:CD8 ratio [HP:0033222]                0.124361  \n",
       "Chronic diarrhea [HP:0002028]                       0.140000  \n",
       "Decreased circulating IgG concentration [HP:000...  0.179936  \n",
       "Decreased circulating IgA concentration [HP:000...  0.183902  \n",
       "B lymphocytopenia [HP:0010976]                      0.190150  \n",
       "Recurrent bacterial skin infections [HP:0005406]    0.370391  \n",
       "Increased proportion of CD4-positive T cells [H...  0.403576  \n",
       "B Acute Lymphoblastic Leukemia [HP:0004812]         1.000000  \n",
       "Autoimmune thrombocytopenia [HP:0001973]            1.000000  \n",
       "Recurrent infections [HP:0002719]                   1.000000  \n",
       "Unusual infection [HP:0032101]                      1.000000  \n",
       "Lymphopenia [HP:0001888]                            1.000000  \n",
       "Abnormal circulating immunoglobulin concentrati...  1.000000  \n",
       "Decreased circulating antibody concentration [H...  1.000000  \n",
       "Abnormal B cell count [HP:0010975]                  1.000000  \n",
       "Abnormal lymphocyte count [HP:0040088]              1.000000  \n",
       "Abnormal B cell subset distribution [HP:0025539]    1.000000  \n",
       "Decreased proportion of CD4-positive T cells [H...  1.000000  \n",
       "Abnormal T cell subset distribution [HP:0025540]    1.000000  \n",
       "Abnormal T cell count [HP:0011839]                  1.000000  \n",
       "Abnormal circulating IgG concentration [HP:0410...  1.000000  \n",
       "Recurrent respiratory infections [HP:0002205]       1.000000  \n",
       "Abnormal circulating IgM concentration [HP:0410...  1.000000  \n",
       "Abnormal circulating IgA concentration [HP:0410...  1.000000  "
      ]
     },
     "execution_count": 9,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "from gpsea.view import summarize_hpo_analysis\n",
    "summarize_hpo_analysis(hpo, asn159ser_result)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "application/vnd.microsoft.datawrangler.viewer.v0+json": {
       "columns": [
        {
         "name": "index",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "Missense",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "oher",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "Corrected p values",
         "rawType": "float64",
         "type": "float"
        },
        {
         "name": "p values",
         "rawType": "float64",
         "type": "float"
        }
       ],
       "conversionMethod": "pd.DataFrame",
       "ref": "0ef8d955-5e8d-4c43-985d-5e04e7302527",
       "rows": [
        [
         "Recurrent otitis media [HP:0000403]",
         "10/33 (30%)",
         "0/21 (0%)",
         "0.14578993694068834",
         "0.004287939321784951"
        ],
        [
         "Recurrent pneumonia [HP:0006532]",
         "13/31 (42%)",
         "1/17 (6%)",
         "0.15656383824671058",
         "0.009209637543924152"
        ],
        [
         "Autoimmune thrombocytopenia [HP:0001973]",
         "6/36 (17%)",
         "0/22 (0%)",
         "0.8317372263884607",
         "0.07338857879898184"
        ],
        [
         "Decreased CD4:CD8 ratio [HP:0033222]",
         "22/43 (51%)",
         "7/23 (30%)",
         "0.8934463422206442",
         "0.12542166987506137"
        ],
        [
         "B lymphocytopenia [HP:0010976]",
         "46/51 (90%)",
         "15/20 (75%)",
         "0.8934463422206442",
         "0.13138916797362415"
        ],
        [
         "Decreased circulating IgG concentration [HP:0004315]",
         "34/41 (83%)",
         "12/18 (67%)",
         "0.9036544850498339",
         "0.18739371277504807"
        ],
        [
         "Recurrent bronchitis [HP:0002837]",
         "3/18 (17%)",
         "0/18 (0%)",
         "0.9036544850498339",
         "0.22857142857142854"
        ],
        [
         "B Acute Lymphoblastic Leukemia [HP:0004812]",
         "1/56 (2%)",
         "2/26 (8%)",
         "0.9036544850498339",
         "0.23486901535682023"
        ],
        [
         "Recurrent oral herpes [HP:0410028]",
         "3/22 (14%)",
         "0/17 (0%)",
         "0.9036544850498339",
         "0.24291497975708506"
        ],
        [
         "Recurrent bacterial skin infections [HP:0005406]",
         "3/26 (12%)",
         "0/17 (0%)",
         "0.9036544850498339",
         "0.26578073089701"
        ],
        [
         "Recurrent respiratory infections [HP:0002205]",
         "25/26 (96%)",
         "7/8 (88%)",
         "1.0",
         "0.4206773618538324"
        ],
        [
         "Decreased proportion of CD4-positive T cells [HP:0032218]",
         "12/29 (41%)",
         "4/14 (29%)",
         "1.0",
         "0.5119811231953932"
        ],
        [
         "T-cell acute lymphoblastic leukemias [HP:0006727]",
         "3/56 (5%)",
         "0/26 (0%)",
         "1.0",
         "0.547877145438121"
        ],
        [
         "Decreased proportion of memory B cells [HP:0030374]",
         "17/18 (94%)",
         "15/17 (88%)",
         "1.0",
         "0.6025974025974027"
        ],
        [
         "Recurrent sinusitis [HP:0011108]",
         "3/30 (10%)",
         "3/21 (14%)",
         "1.0",
         "0.6804429449855799"
        ],
        [
         "Recurrent meningitis [HP:0006946]",
         "1/19 (5%)",
         "0/17 (0%)",
         "1.0",
         "1.0"
        ],
        [
         "Abnormal B cell subset distribution [HP:0025539]",
         "19/19 (100%)",
         "16/16 (100%)",
         "1.0",
         "1.0"
        ],
        [
         "Sepsis [HP:0100806]",
         "2/19 (11%)",
         "1/17 (6%)",
         "1.0",
         "1.0"
        ],
        [
         "Abnormal T cell subset distribution [HP:0025540]",
         "32/32 (100%)",
         "10/10 (100%)",
         "1.0",
         "1.0"
        ],
        [
         "Abnormal T cell count [HP:0011839]",
         "32/32 (100%)",
         "11/11 (100%)",
         "1.0",
         "1.0"
        ],
        [
         "Abnormal circulating IgG concentration [HP:0410242]",
         "34/34 (100%)",
         "12/12 (100%)",
         "1.0",
         "1.0"
        ],
        [
         "Abnormal circulating IgM concentration [HP:0410243]",
         "34/34 (100%)",
         "15/15 (100%)",
         "1.0",
         "1.0"
        ],
        [
         "Abnormal circulating IgA concentration [HP:0410240]",
         "34/34 (100%)",
         "16/16 (100%)",
         "1.0",
         "1.0"
        ],
        [
         "Decreased circulating IgA concentration [HP:0002720]",
         "34/43 (79%)",
         "16/20 (80%)",
         "1.0",
         "1.0"
        ],
        [
         "Decreased circulating total IgM [HP:0002850]",
         "34/45 (76%)",
         "15/20 (75%)",
         "1.0",
         "1.0"
        ],
        [
         "Recurrent infections [HP:0002719]",
         "39/39 (100%)",
         "13/13 (100%)",
         "1.0",
         "1.0"
        ],
        [
         "Chronic diarrhea [HP:0002028]",
         "4/29 (14%)",
         "3/21 (14%)",
         "1.0",
         "1.0"
        ],
        [
         "Unusual infection [HP:0032101]",
         "42/42 (100%)",
         "13/13 (100%)",
         "1.0",
         "1.0"
        ],
        [
         "Lymphopenia [HP:0001888]",
         "46/46 (100%)",
         "15/15 (100%)",
         "1.0",
         "1.0"
        ],
        [
         "Abnormal circulating immunoglobulin concentration [HP:0010701]",
         "49/49 (100%)",
         "20/20 (100%)",
         "1.0",
         "1.0"
        ],
        [
         "Decreased circulating antibody concentration [HP:0004313]",
         "49/49 (100%)",
         "20/20 (100%)",
         "1.0",
         "1.0"
        ],
        [
         "Abnormal B cell count [HP:0010975]",
         "49/49 (100%)",
         "21/21 (100%)",
         "1.0",
         "1.0"
        ],
        [
         "Abnormal lymphocyte count [HP:0040088]",
         "52/52 (100%)",
         "21/21 (100%)",
         "1.0",
         "1.0"
        ],
        [
         "Increased proportion of CD4-positive T cells [HP:0032219]",
         "6/24 (25%)",
         "4/14 (29%)",
         "1.0",
         "1.0"
        ]
       ],
       "shape": {
        "columns": 4,
        "rows": 34
       }
      },
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th>Allele group</th>\n",
       "      <th>Missense</th>\n",
       "      <th>oher</th>\n",
       "      <th>Corrected p values</th>\n",
       "      <th>p values</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>Recurrent otitis media [HP:0000403]</th>\n",
       "      <td>10/33 (30%)</td>\n",
       "      <td>0/21 (0%)</td>\n",
       "      <td>0.145790</td>\n",
       "      <td>0.004288</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Recurrent pneumonia [HP:0006532]</th>\n",
       "      <td>13/31 (42%)</td>\n",
       "      <td>1/17 (6%)</td>\n",
       "      <td>0.156564</td>\n",
       "      <td>0.009210</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Autoimmune thrombocytopenia [HP:0001973]</th>\n",
       "      <td>6/36 (17%)</td>\n",
       "      <td>0/22 (0%)</td>\n",
       "      <td>0.831737</td>\n",
       "      <td>0.073389</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Decreased CD4:CD8 ratio [HP:0033222]</th>\n",
       "      <td>22/43 (51%)</td>\n",
       "      <td>7/23 (30%)</td>\n",
       "      <td>0.893446</td>\n",
       "      <td>0.125422</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>B lymphocytopenia [HP:0010976]</th>\n",
       "      <td>46/51 (90%)</td>\n",
       "      <td>15/20 (75%)</td>\n",
       "      <td>0.893446</td>\n",
       "      <td>0.131389</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Decreased circulating IgG concentration [HP:0004315]</th>\n",
       "      <td>34/41 (83%)</td>\n",
       "      <td>12/18 (67%)</td>\n",
       "      <td>0.903654</td>\n",
       "      <td>0.187394</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Recurrent bronchitis [HP:0002837]</th>\n",
       "      <td>3/18 (17%)</td>\n",
       "      <td>0/18 (0%)</td>\n",
       "      <td>0.903654</td>\n",
       "      <td>0.228571</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>B Acute Lymphoblastic Leukemia [HP:0004812]</th>\n",
       "      <td>1/56 (2%)</td>\n",
       "      <td>2/26 (8%)</td>\n",
       "      <td>0.903654</td>\n",
       "      <td>0.234869</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Recurrent oral herpes [HP:0410028]</th>\n",
       "      <td>3/22 (14%)</td>\n",
       "      <td>0/17 (0%)</td>\n",
       "      <td>0.903654</td>\n",
       "      <td>0.242915</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Recurrent bacterial skin infections [HP:0005406]</th>\n",
       "      <td>3/26 (12%)</td>\n",
       "      <td>0/17 (0%)</td>\n",
       "      <td>0.903654</td>\n",
       "      <td>0.265781</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Recurrent respiratory infections [HP:0002205]</th>\n",
       "      <td>25/26 (96%)</td>\n",
       "      <td>7/8 (88%)</td>\n",
       "      <td>1.000000</td>\n",
       "      <td>0.420677</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Decreased proportion of CD4-positive T cells [HP:0032218]</th>\n",
       "      <td>12/29 (41%)</td>\n",
       "      <td>4/14 (29%)</td>\n",
       "      <td>1.000000</td>\n",
       "      <td>0.511981</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>T-cell acute lymphoblastic leukemias [HP:0006727]</th>\n",
       "      <td>3/56 (5%)</td>\n",
       "      <td>0/26 (0%)</td>\n",
       "      <td>1.000000</td>\n",
       "      <td>0.547877</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Decreased proportion of memory B cells [HP:0030374]</th>\n",
       "      <td>17/18 (94%)</td>\n",
       "      <td>15/17 (88%)</td>\n",
       "      <td>1.000000</td>\n",
       "      <td>0.602597</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Recurrent sinusitis [HP:0011108]</th>\n",
       "      <td>3/30 (10%)</td>\n",
       "      <td>3/21 (14%)</td>\n",
       "      <td>1.000000</td>\n",
       "      <td>0.680443</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Recurrent meningitis [HP:0006946]</th>\n",
       "      <td>1/19 (5%)</td>\n",
       "      <td>0/17 (0%)</td>\n",
       "      <td>1.000000</td>\n",
       "      <td>1.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Abnormal B cell subset distribution [HP:0025539]</th>\n",
       "      <td>19/19 (100%)</td>\n",
       "      <td>16/16 (100%)</td>\n",
       "      <td>1.000000</td>\n",
       "      <td>1.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Sepsis [HP:0100806]</th>\n",
       "      <td>2/19 (11%)</td>\n",
       "      <td>1/17 (6%)</td>\n",
       "      <td>1.000000</td>\n",
       "      <td>1.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Abnormal T cell subset distribution [HP:0025540]</th>\n",
       "      <td>32/32 (100%)</td>\n",
       "      <td>10/10 (100%)</td>\n",
       "      <td>1.000000</td>\n",
       "      <td>1.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Abnormal T cell count [HP:0011839]</th>\n",
       "      <td>32/32 (100%)</td>\n",
       "      <td>11/11 (100%)</td>\n",
       "      <td>1.000000</td>\n",
       "      <td>1.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Abnormal circulating IgG concentration [HP:0410242]</th>\n",
       "      <td>34/34 (100%)</td>\n",
       "      <td>12/12 (100%)</td>\n",
       "      <td>1.000000</td>\n",
       "      <td>1.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Abnormal circulating IgM concentration [HP:0410243]</th>\n",
       "      <td>34/34 (100%)</td>\n",
       "      <td>15/15 (100%)</td>\n",
       "      <td>1.000000</td>\n",
       "      <td>1.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Abnormal circulating IgA concentration [HP:0410240]</th>\n",
       "      <td>34/34 (100%)</td>\n",
       "      <td>16/16 (100%)</td>\n",
       "      <td>1.000000</td>\n",
       "      <td>1.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Decreased circulating IgA concentration [HP:0002720]</th>\n",
       "      <td>34/43 (79%)</td>\n",
       "      <td>16/20 (80%)</td>\n",
       "      <td>1.000000</td>\n",
       "      <td>1.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Decreased circulating total IgM [HP:0002850]</th>\n",
       "      <td>34/45 (76%)</td>\n",
       "      <td>15/20 (75%)</td>\n",
       "      <td>1.000000</td>\n",
       "      <td>1.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Recurrent infections [HP:0002719]</th>\n",
       "      <td>39/39 (100%)</td>\n",
       "      <td>13/13 (100%)</td>\n",
       "      <td>1.000000</td>\n",
       "      <td>1.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Chronic diarrhea [HP:0002028]</th>\n",
       "      <td>4/29 (14%)</td>\n",
       "      <td>3/21 (14%)</td>\n",
       "      <td>1.000000</td>\n",
       "      <td>1.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Unusual infection [HP:0032101]</th>\n",
       "      <td>42/42 (100%)</td>\n",
       "      <td>13/13 (100%)</td>\n",
       "      <td>1.000000</td>\n",
       "      <td>1.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Lymphopenia [HP:0001888]</th>\n",
       "      <td>46/46 (100%)</td>\n",
       "      <td>15/15 (100%)</td>\n",
       "      <td>1.000000</td>\n",
       "      <td>1.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Abnormal circulating immunoglobulin concentration [HP:0010701]</th>\n",
       "      <td>49/49 (100%)</td>\n",
       "      <td>20/20 (100%)</td>\n",
       "      <td>1.000000</td>\n",
       "      <td>1.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Decreased circulating antibody concentration [HP:0004313]</th>\n",
       "      <td>49/49 (100%)</td>\n",
       "      <td>20/20 (100%)</td>\n",
       "      <td>1.000000</td>\n",
       "      <td>1.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Abnormal B cell count [HP:0010975]</th>\n",
       "      <td>49/49 (100%)</td>\n",
       "      <td>21/21 (100%)</td>\n",
       "      <td>1.000000</td>\n",
       "      <td>1.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Abnormal lymphocyte count [HP:0040088]</th>\n",
       "      <td>52/52 (100%)</td>\n",
       "      <td>21/21 (100%)</td>\n",
       "      <td>1.000000</td>\n",
       "      <td>1.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Increased proportion of CD4-positive T cells [HP:0032219]</th>\n",
       "      <td>6/24 (25%)</td>\n",
       "      <td>4/14 (29%)</td>\n",
       "      <td>1.000000</td>\n",
       "      <td>1.000000</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "Allele group                                            Missense  \\\n",
       "Recurrent otitis media [HP:0000403]                  10/33 (30%)   \n",
       "Recurrent pneumonia [HP:0006532]                     13/31 (42%)   \n",
       "Autoimmune thrombocytopenia [HP:0001973]              6/36 (17%)   \n",
       "Decreased CD4:CD8 ratio [HP:0033222]                 22/43 (51%)   \n",
       "B lymphocytopenia [HP:0010976]                       46/51 (90%)   \n",
       "Decreased circulating IgG concentration [HP:000...   34/41 (83%)   \n",
       "Recurrent bronchitis [HP:0002837]                     3/18 (17%)   \n",
       "B Acute Lymphoblastic Leukemia [HP:0004812]            1/56 (2%)   \n",
       "Recurrent oral herpes [HP:0410028]                    3/22 (14%)   \n",
       "Recurrent bacterial skin infections [HP:0005406]      3/26 (12%)   \n",
       "Recurrent respiratory infections [HP:0002205]        25/26 (96%)   \n",
       "Decreased proportion of CD4-positive T cells [H...   12/29 (41%)   \n",
       "T-cell acute lymphoblastic leukemias [HP:0006727]      3/56 (5%)   \n",
       "Decreased proportion of memory B cells [HP:0030...   17/18 (94%)   \n",
       "Recurrent sinusitis [HP:0011108]                      3/30 (10%)   \n",
       "Recurrent meningitis [HP:0006946]                      1/19 (5%)   \n",
       "Abnormal B cell subset distribution [HP:0025539]    19/19 (100%)   \n",
       "Sepsis [HP:0100806]                                   2/19 (11%)   \n",
       "Abnormal T cell subset distribution [HP:0025540]    32/32 (100%)   \n",
       "Abnormal T cell count [HP:0011839]                  32/32 (100%)   \n",
       "Abnormal circulating IgG concentration [HP:0410...  34/34 (100%)   \n",
       "Abnormal circulating IgM concentration [HP:0410...  34/34 (100%)   \n",
       "Abnormal circulating IgA concentration [HP:0410...  34/34 (100%)   \n",
       "Decreased circulating IgA concentration [HP:000...   34/43 (79%)   \n",
       "Decreased circulating total IgM [HP:0002850]         34/45 (76%)   \n",
       "Recurrent infections [HP:0002719]                   39/39 (100%)   \n",
       "Chronic diarrhea [HP:0002028]                         4/29 (14%)   \n",
       "Unusual infection [HP:0032101]                      42/42 (100%)   \n",
       "Lymphopenia [HP:0001888]                            46/46 (100%)   \n",
       "Abnormal circulating immunoglobulin concentrati...  49/49 (100%)   \n",
       "Decreased circulating antibody concentration [H...  49/49 (100%)   \n",
       "Abnormal B cell count [HP:0010975]                  49/49 (100%)   \n",
       "Abnormal lymphocyte count [HP:0040088]              52/52 (100%)   \n",
       "Increased proportion of CD4-positive T cells [H...    6/24 (25%)   \n",
       "\n",
       "Allele group                                                oher  \\\n",
       "Recurrent otitis media [HP:0000403]                    0/21 (0%)   \n",
       "Recurrent pneumonia [HP:0006532]                       1/17 (6%)   \n",
       "Autoimmune thrombocytopenia [HP:0001973]               0/22 (0%)   \n",
       "Decreased CD4:CD8 ratio [HP:0033222]                  7/23 (30%)   \n",
       "B lymphocytopenia [HP:0010976]                       15/20 (75%)   \n",
       "Decreased circulating IgG concentration [HP:000...   12/18 (67%)   \n",
       "Recurrent bronchitis [HP:0002837]                      0/18 (0%)   \n",
       "B Acute Lymphoblastic Leukemia [HP:0004812]            2/26 (8%)   \n",
       "Recurrent oral herpes [HP:0410028]                     0/17 (0%)   \n",
       "Recurrent bacterial skin infections [HP:0005406]       0/17 (0%)   \n",
       "Recurrent respiratory infections [HP:0002205]          7/8 (88%)   \n",
       "Decreased proportion of CD4-positive T cells [H...    4/14 (29%)   \n",
       "T-cell acute lymphoblastic leukemias [HP:0006727]      0/26 (0%)   \n",
       "Decreased proportion of memory B cells [HP:0030...   15/17 (88%)   \n",
       "Recurrent sinusitis [HP:0011108]                      3/21 (14%)   \n",
       "Recurrent meningitis [HP:0006946]                      0/17 (0%)   \n",
       "Abnormal B cell subset distribution [HP:0025539]    16/16 (100%)   \n",
       "Sepsis [HP:0100806]                                    1/17 (6%)   \n",
       "Abnormal T cell subset distribution [HP:0025540]    10/10 (100%)   \n",
       "Abnormal T cell count [HP:0011839]                  11/11 (100%)   \n",
       "Abnormal circulating IgG concentration [HP:0410...  12/12 (100%)   \n",
       "Abnormal circulating IgM concentration [HP:0410...  15/15 (100%)   \n",
       "Abnormal circulating IgA concentration [HP:0410...  16/16 (100%)   \n",
       "Decreased circulating IgA concentration [HP:000...   16/20 (80%)   \n",
       "Decreased circulating total IgM [HP:0002850]         15/20 (75%)   \n",
       "Recurrent infections [HP:0002719]                   13/13 (100%)   \n",
       "Chronic diarrhea [HP:0002028]                         3/21 (14%)   \n",
       "Unusual infection [HP:0032101]                      13/13 (100%)   \n",
       "Lymphopenia [HP:0001888]                            15/15 (100%)   \n",
       "Abnormal circulating immunoglobulin concentrati...  20/20 (100%)   \n",
       "Decreased circulating antibody concentration [H...  20/20 (100%)   \n",
       "Abnormal B cell count [HP:0010975]                  21/21 (100%)   \n",
       "Abnormal lymphocyte count [HP:0040088]              21/21 (100%)   \n",
       "Increased proportion of CD4-positive T cells [H...    4/14 (29%)   \n",
       "\n",
       "Allele group                                        Corrected p values  \\\n",
       "Recurrent otitis media [HP:0000403]                           0.145790   \n",
       "Recurrent pneumonia [HP:0006532]                              0.156564   \n",
       "Autoimmune thrombocytopenia [HP:0001973]                      0.831737   \n",
       "Decreased CD4:CD8 ratio [HP:0033222]                          0.893446   \n",
       "B lymphocytopenia [HP:0010976]                                0.893446   \n",
       "Decreased circulating IgG concentration [HP:000...            0.903654   \n",
       "Recurrent bronchitis [HP:0002837]                             0.903654   \n",
       "B Acute Lymphoblastic Leukemia [HP:0004812]                   0.903654   \n",
       "Recurrent oral herpes [HP:0410028]                            0.903654   \n",
       "Recurrent bacterial skin infections [HP:0005406]              0.903654   \n",
       "Recurrent respiratory infections [HP:0002205]                 1.000000   \n",
       "Decreased proportion of CD4-positive T cells [H...            1.000000   \n",
       "T-cell acute lymphoblastic leukemias [HP:0006727]             1.000000   \n",
       "Decreased proportion of memory B cells [HP:0030...            1.000000   \n",
       "Recurrent sinusitis [HP:0011108]                              1.000000   \n",
       "Recurrent meningitis [HP:0006946]                             1.000000   \n",
       "Abnormal B cell subset distribution [HP:0025539]              1.000000   \n",
       "Sepsis [HP:0100806]                                           1.000000   \n",
       "Abnormal T cell subset distribution [HP:0025540]              1.000000   \n",
       "Abnormal T cell count [HP:0011839]                            1.000000   \n",
       "Abnormal circulating IgG concentration [HP:0410...            1.000000   \n",
       "Abnormal circulating IgM concentration [HP:0410...            1.000000   \n",
       "Abnormal circulating IgA concentration [HP:0410...            1.000000   \n",
       "Decreased circulating IgA concentration [HP:000...            1.000000   \n",
       "Decreased circulating total IgM [HP:0002850]                  1.000000   \n",
       "Recurrent infections [HP:0002719]                             1.000000   \n",
       "Chronic diarrhea [HP:0002028]                                 1.000000   \n",
       "Unusual infection [HP:0032101]                                1.000000   \n",
       "Lymphopenia [HP:0001888]                                      1.000000   \n",
       "Abnormal circulating immunoglobulin concentrati...            1.000000   \n",
       "Decreased circulating antibody concentration [H...            1.000000   \n",
       "Abnormal B cell count [HP:0010975]                            1.000000   \n",
       "Abnormal lymphocyte count [HP:0040088]                        1.000000   \n",
       "Increased proportion of CD4-positive T cells [H...            1.000000   \n",
       "\n",
       "Allele group                                        p values  \n",
       "Recurrent otitis media [HP:0000403]                 0.004288  \n",
       "Recurrent pneumonia [HP:0006532]                    0.009210  \n",
       "Autoimmune thrombocytopenia [HP:0001973]            0.073389  \n",
       "Decreased CD4:CD8 ratio [HP:0033222]                0.125422  \n",
       "B lymphocytopenia [HP:0010976]                      0.131389  \n",
       "Decreased circulating IgG concentration [HP:000...  0.187394  \n",
       "Recurrent bronchitis [HP:0002837]                   0.228571  \n",
       "B Acute Lymphoblastic Leukemia [HP:0004812]         0.234869  \n",
       "Recurrent oral herpes [HP:0410028]                  0.242915  \n",
       "Recurrent bacterial skin infections [HP:0005406]    0.265781  \n",
       "Recurrent respiratory infections [HP:0002205]       0.420677  \n",
       "Decreased proportion of CD4-positive T cells [H...  0.511981  \n",
       "T-cell acute lymphoblastic leukemias [HP:0006727]   0.547877  \n",
       "Decreased proportion of memory B cells [HP:0030...  0.602597  \n",
       "Recurrent sinusitis [HP:0011108]                    0.680443  \n",
       "Recurrent meningitis [HP:0006946]                   1.000000  \n",
       "Abnormal B cell subset distribution [HP:0025539]    1.000000  \n",
       "Sepsis [HP:0100806]                                 1.000000  \n",
       "Abnormal T cell subset distribution [HP:0025540]    1.000000  \n",
       "Abnormal T cell count [HP:0011839]                  1.000000  \n",
       "Abnormal circulating IgG concentration [HP:0410...  1.000000  \n",
       "Abnormal circulating IgM concentration [HP:0410...  1.000000  \n",
       "Abnormal circulating IgA concentration [HP:0410...  1.000000  \n",
       "Decreased circulating IgA concentration [HP:000...  1.000000  \n",
       "Decreased circulating total IgM [HP:0002850]        1.000000  \n",
       "Recurrent infections [HP:0002719]                   1.000000  \n",
       "Chronic diarrhea [HP:0002028]                       1.000000  \n",
       "Unusual infection [HP:0032101]                      1.000000  \n",
       "Lymphopenia [HP:0001888]                            1.000000  \n",
       "Abnormal circulating immunoglobulin concentrati...  1.000000  \n",
       "Decreased circulating antibody concentration [H...  1.000000  \n",
       "Abnormal B cell count [HP:0010975]                  1.000000  \n",
       "Abnormal lymphocyte count [HP:0040088]              1.000000  \n",
       "Increased proportion of CD4-positive T cells [H...  1.000000  "
      ]
     },
     "execution_count": 10,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "from gpsea.analysis.predicate import variant_effect\n",
    "from gpsea.model import VariantEffect\n",
    "\n",
    "missense = variant_effect(VariantEffect.MISSENSE_VARIANT,  mane_tx_id)\n",
    "missense_clf = monoallelic_classifier(\n",
    "    a_predicate=missense,\n",
    "    b_predicate=~missense,\n",
    "    a_label=\"Missense\",\n",
    "    b_label=\"oher\"\n",
    ")\n",
    "missense_result = analysis.compare_genotype_vs_phenotypes(\n",
    "    cohort=cohort,\n",
    "    gt_clf=missense_clf,\n",
    "    pheno_clfs=pheno_clfs,\n",
    ")\n",
    "summarize_hpo_analysis(hpo, missense_result)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Summary"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "metadata": {},
   "outputs": [],
   "source": [
    "caption = \"\"\"The variant p.Asn159Ser was functionally characterized to be dominant-negative and result in a combined-immunodeficiency phenotype that \n",
    "was distinct from other IKZF1 variants \\\\cite{ by Boutboul et al. 2019}.\"\"\"\n",
    "\n",
    "from gpseacs.report import GpseaAnalysisReport, GPAnalysisResultSummary\n",
    "\n",
    "fet_results = (\n",
    "    GPAnalysisResultSummary.from_multi(\n",
    "        result=asn159ser_result,\n",
    "    ),\n",
    "    GPAnalysisResultSummary.from_multi(\n",
    "        result=missense_result,\n",
    "    ),\n",
    ")\n",
    "\n",
    "report = GpseaAnalysisReport(name=gene_symbol, \n",
    "                             cohort=cohort, \n",
    "                             fet_results=fet_results,\n",
    "                             gene_symbol=gene_symbol,\n",
    "                             mane_tx_id=mane_tx_id,\n",
    "                             mane_protein_id=mane_protein_id,\n",
    "                             caption=caption)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<!DOCTYPE html>\n",
       "<html lang=\"en\">\n",
       "<head>\n",
       "  <meta charset=\"utf-8\">\n",
       "  <title>Cohort</title>\n",
       "    <style>\n",
       "    table {\n",
       "      border-collapse: collapse;\n",
       "      margin: 25px 0;\n",
       "      font-size: 0.9em;\n",
       "      font-family: sans-serif;\n",
       "      min-width: 400px;\n",
       "      box-shadow: 0 0 20px rgba(0, 0, 0, 0.15);\n",
       "    }\n",
       "\n",
       "    .table .column-1 {\n",
       "      text-align: left;\n",
       "    }\n",
       "    th {\n",
       "      background-color: LightSkyBlue;\n",
       "      border: 1px solid #dddddd;\n",
       "      text-align: left;\n",
       "      padding: 2px;\n",
       "      font-weight: bold;\n",
       "      font-size: 120%;\n",
       "      min-width: 100px;\n",
       "      border: 1px solid #ddd;\n",
       "      padding: 8px;\n",
       "        \n",
       "    }\n",
       "\n",
       "    tr {\n",
       "      border: 1px solid #dddddd;\n",
       "    }\n",
       "\n",
       "    td {\n",
       "      padding: 2px;\n",
       "      font-weight: bold;\n",
       "    }\n",
       "\n",
       "    tr:nth-child(even) {\n",
       "      background-color: #f2f2f2;\n",
       "    }\n",
       "\n",
       "    .table td, tr {\n",
       "      text-align: right;\n",
       "    }\n",
       "\n",
       "    .lft {\n",
       "      text-align: left;\n",
       "    }\n",
       "\n",
       "    div {\n",
       "      display: block;\n",
       "      width: 100%;\n",
       "      padding-right: 1%;\n",
       "      margin-bottom: 20px; /* Add margin to separate divs */\n",
       "    }\n",
       "\n",
       "    p {\n",
       "      width: 75%;\n",
       "    }\n",
       "\n",
       "    caption {\n",
       "      caption-side: top;\n",
       "      text-align: left;\n",
       "      padding-bottom: 10px;\n",
       "      font-weight: bold;\n",
       "    }\n",
       "  </style>\n",
       "</head>\n",
       "\n",
       "<body>\n",
       "  <h1>IKZF1 Summary</h1>\n",
       "  <p>The cohort comprised 82 individuals (34 females, 37 males, 11 with unknown sex). 5 of these individuals were reported to be deceased. A total of 66 HPO terms were used to annotate the cohort. Disease diagnosis: Immunodeficiency, common variable, 13 (OMIM:616873). The variant p.Asn159Ser was functionally characterized to be dominant-negative and result in a combined-immunodeficiency phenotype that \n",
       "was distinct from other IKZF1 variants \\cite{ by Boutboul et al. 2019}. A total of 26 unique variant alleles were found in IKZF1 (transcript: NM_006060.6, protein id: NP_006051.1). HPO version: 2025-01-16. GPSEA version: 0.9.6.dev0.</p>\n",
       "  \n",
       "  \n",
       "    \n",
       "    <table>\n",
       "      <caption style=\"color: black;\">\n",
       "          Fisher Exact Test performed to compare HPO annotation frequency with respect to p.Asn159Ser and Other variant. Total of\n",
       "          29 tests were performed.\n",
       "      </caption>\n",
       "          <tbody>\n",
       "              <tr class=\"strng\">\n",
       "                  <th>HPO Term</th>\n",
       "                  <th>p.Asn159Ser</th>\n",
       "                  <th>Other variant</th>\n",
       "                  <th>p-val</th>\n",
       "                  <th>adj. p-val</th>\n",
       "              </tr>\n",
       "              \n",
       "              <tr>\n",
       "                  <td class=\"lft\">Recurrent pneumonia [HP:0006532]</td>\n",
       "                  <td class=\"lft\">7/9 (78%)</td>\n",
       "                  <td class=\"lft\">7/39 (18%)</td>\n",
       "                  <td class=\"lft\">0.001</td>\n",
       "                  <td class=\"lft\">0.035</td>\n",
       "              </tr>\n",
       "              \n",
       "              <tr>\n",
       "                  <td class=\"lft\">T-cell acute lymphoblastic leukemias [HP:0006727]</td>\n",
       "                  <td class=\"lft\">3/13 (23%)</td>\n",
       "                  <td class=\"lft\">0/69 (0%)</td>\n",
       "                  <td class=\"lft\">0.003</td>\n",
       "                  <td class=\"lft\">0.047</td>\n",
       "              </tr>\n",
       "              \n",
       "            </tbody>\n",
       "      </table>\n",
       "      \n",
       "\n",
       "  \n",
       "    \n",
       "      <table>\n",
       "        <caption style=\"color: black;\">\n",
       "            Fisher Exact Test performed to compare HPO annotation frequency with respect to Missense and oher.\n",
       "        </caption>\n",
       "            <tbody>\n",
       "                <tr class=\"strng\">\n",
       "                    <th>Genotype (A)</th>\n",
       "                    <th>Genotype (B)</th>\n",
       "                  <th>Tests performed</th>\n",
       "                  <th>Significant tests</th>\n",
       "                </tr>\n",
       "                \n",
       "                <tr>\n",
       "                    <td class=\"lft\">Missense</td>\n",
       "                    <td class=\"lft\">oher</td>\n",
       "                    <td class=\"lft\">34</td>\n",
       "                    <td class=\"lft\">0</td>\n",
       "                </tr>\n",
       "              </tbody>\n",
       "        </table>\n",
       "      \n",
       "\n",
       "  \n",
       "  \n",
       "  \n",
       "  \n",
       "  \n",
       "\n",
       "\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<gpseacs.report._api.HtmlGpseaNotebookSummarizer at 0x7d2533ae7260>"
      ]
     },
     "execution_count": 12,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "from gpseacs.report import GpseaNotebookSummarizer\n",
    "summarizer = GpseaNotebookSummarizer(hpo=hpo, gpsea_version=gpsea.__version__)\n",
    "summarizer.summarize_report(report=report)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Figure saved to ../../supplement/img/IKZF1_protein_diagram-draft.pdf\n",
      "Output to ../../supplement/tex/IKZF1_summary_draft.tex\n"
     ]
    }
   ],
   "source": [
    "summarizer.process_latex(report=report, protein_fig=IKZF1_fig)"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "venv",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.12.3"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
